FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称2-((8-((3R)-3-AMINO-1-PIPERIDINYL)-7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-2,6-DIOXO-1H-PURIN-1-YL)METHYL)-4-QUINAZOLINECARBOXYLIC ACID
异名/同义词2-((8-((3R)-3-AMINO-1-PIPERIDINYL)-7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-2,6-DIOXO-1H-PURIN-1-YL)METHYL)-4-QUINAZOLINECARBOXYLIC ACID
4-QUINAZOLINECARBOXYLIC ACID, 2-((8-((3R)-3-AMINO-1-PIPERIDINYL)-7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-2,6-DIOXO-1H-PURIN-1-YL)METHYL)-
LINAGLIPTIN METABOLITE M503(1)
CAS登记号1807608-08-7
物质唯一标识(Unique Ingredient Identifier)24KFS7IE11
分子式C25H26N8O4
国际化合物标识(International Chemical Identifier,InChI)RGTNITURKUFCGN-OAHLLOKOSA-N
SMILESc1cc2c(c(nc(n2)Cn3c(=O)n(C)c4c(c3=O)n(c(n4)N5C[C@@H](CCC5)N)CC#CC)C(O)=O)cc1
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
    扩展资源
    ©2006-2024 Drugfuture->FDA Global Substance Registration System